Virtual discovery of a hetero-cyclic compound from the Universal Natural Product Database (UNPD36) as a potential inhibitor of interleukin-33: molecular docking and dynamic simulations

References

• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindah, E. (2015). Gromacs: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
   Google Scholar
• Arshad, M. I., Khan, H. A., Noel, G., Piquet-Pellorce, C., & Samson, M. (2016). Potential therapeutic aspects of alarmin cytokine interleukin 33 or its inhibitors in various diseases. Clinical Therapeutics, 38(5), 1000–1016.e1. https://doi.org/10.1016/j.clinthera.2016.02.021
   Google Scholar
• Azazi, E. A., Elshora, A. E., Tantawy, E. A., & Elsayd, M. A. (2014). Serum levels of Interleukin-33 and its soluble receptor ST2 in asthmatic patients. Egyptian Journal of Chest Diseases and Tuberculosis, 63(2), 279–284. https://doi.org/10.1016/j.ejcdt.2013.11.005
   Google Scholar
• Bailey, A. G., & Lowe, C. P. (2009). MILCH SHAKE: An efficient method for constraint dynamics applied to alkanes. Journal of Computational Chemistry, 30(15), 2485–2493. https://doi.org/10.1002/jcc.21237
   PubMed Web of Science ®Google Scholar
• Cayrol, C., & Girard, J. P. (2014). IL-33: An alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Current Opinion in Immunology, 31, 31–37. https://doi.org/10.1016/j.coi.2014.09.004
   PubMed Web of Science ®Google Scholar
• Cevikbas, F., & Steinhoff, M. (2012). IL-33: A novel danger signal system in atopic dermatitis. Journal of Investigative Dermatology, 132(5), 1326–1329. https://doi.org/10.1038/jid.2012.66
   Google Scholar
• Chan, B. C. L., Lam, C. W. K., Tam, L. S., & Wong, C. K. (2019). IL33: Roles in allergic inflammation and therapeutic perspectives. Frontiers in Immunology, 10, 364. https://doi.org/10.3389/fimmu.2019.00364
   Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 1–13. https://doi.org/10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• Dallakyan, S., & Olson, A. J. (2015). Small-molecule library screening by docking with PyRx. Methods in Molecular Biology, 1263, 243–250. https://doi.org/10.1007/978-1-4939-2269-7_19
   PubMedGoogle Scholar
• Daoud, I., Melkemi, N., Salah, T., & Ghalem, S. (2018). Combined QSAR, molecular docking and molecular dynamics study on new acetylcholinesterase and butyrylcholinesterase inhibitors. Computational Biology and Chemistry, 74, 304–326. https://doi.org/10.1016/j.compbiolchem.2018.03.021
   PubMed Web of Science ®Google Scholar
• Ding, W., Zou, G. L., Zhang, W., Lai, X. N., Chen, H. W., & Xiong, L. X. (2018). Interleukin-33: Its emerging role in allergic diseases. Molecules, 23(7), 1665. https://doi.org/10.3390/molecules23071665
   PubMed Web of Science ®Google Scholar
• Gu, J., Gui, Y., Chen, L., Yuan, G., Lu, H. Z., & Xu, X. (2013). Use of natural products as chemical library for drug discovery and network pharmacology. PLoS One, 8(4), e62839. https://doi.org/10.1371/journal.pone.0062839
   PubMed Web of Science ®Google Scholar
• Gupta, M. K., Vemula, S., Donde, R., Gouda, G., Behera, L., & Vadde, R. (2020). In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. Journal of Biomolecular Structure and Dynamics, 39(7), 2617–2627. https://doi.org/10.1080/07391102.2020.1751300
   Google Scholar
• Halgren, T. A. (1996). Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. Journal of Computational Chemistry, 17(5–6), 490–519. https://doi.org/10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P
   Web of Science ®Google Scholar
• Holgado, A., Braun, H., Van Nuffel, E., Detry, S., Schuijs, M. J., Deswarte, K., Vergote, K., Haegman, M., Baudelet, G., Haustraete, J., Hammad, H., Lambrecht, B. N., Savvides, S. N., Afonina, I. S., & Beyaert, R. (2019). IL-33trap is a novel IL-33–neutralizing biologic that inhibits allergic airway inflammation. Journal of Allergy and Clinical Immunology, 144(1), 204–215. https://doi.org/10.1016/j.jaci.2019.02.028
   PubMed Web of Science ®Google Scholar
• Holgate, S. T., Walker, S., West, B., & Boycott, K. (2019). The future of asthma care: Personalized asthma treatment. Clinics in Chest Medicine, 40(1), 227–241. https://doi.org/10.1016/j.ccm.2018.10.013
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 00018. https://doi.org/10.1016/0263-7855(96)5
   Google Scholar
• Ikeguchi, M. (2004). Partial rigid-body dynamics in NPT, NPAT and NP gamma T ensembles for proteins and membranes. Journal of Computational Chemistry, 25(4), 529–541. https://doi.org/10.1002/jcc.10402
   PubMed Web of Science ®Google Scholar
• Kacem, O., Kaabachi, W., Dhifallah, I. B., Hamzaoui, A., & Hamzaoui, K. (2018). Elevated expression of TSLP and IL-33 in Behçet’s disease skin lesions: IL-37 alleviate inflammatory effect of TSLP. Clinical Immunology, 192, 14–19. https://doi.org/10.1016/j.clim.2018.03.016
   PubMed Web of Science ®Google Scholar
• Kim, S., Lee, J., Jo, S., Brooks, C. L., Lee, H. S., & Im, W. (2017). CHARMM-GUI ligand reader and modeler for CHARMM force field generation of small molecules. Journal of Computational Chemistry, 38(21), 1879–1886. https://doi.org/10.1002/jcc.24829
   PubMed Web of Science ®Google Scholar
• Kim, Y. K., Cho, S. H., Mushtaq, A. U., Cho, H., Jung, Y. W., Byun, Y., & Jeon, Y. H. (2016). Discovery of an interleukin 33 inhibitor by molecular docking simulation and NMR analysis. Bulletin of the Korean Chemical Society, 37(2), 117–118. https://doi.org/10.1002/bkcs.10637
   Web of Science ®Google Scholar
• Kumari, R., Kumar, R., & Lynn, A. (2014). G-mmpbsa – A GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Liu, X., Hammel, M., He, Y., Tainer, J. A., Jeng, U. S., Zhang, L., Wang, S., & Wang, X. (2013). Structural insights into the interaction of IL-33 with its receptors. Proceedings of the National Academy of Sciences of the United States of America, 110(37), 14918–14923. https://doi.org/10.1073/pnas.1308651110
   PubMed Web of Science ®Google Scholar
• Milovanovic, M., Volarevic, V., Radosavljevic, G., Jovanovic, I., Pejnovic, N., Arsenijevic, N., & Lukic, M. L. (2012). IL-33/ST2 axis in inflammation and immunopathology. Immunologic Research, 52, 89–99. https://doi.org/10.1007/s12026-012-8283-9
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., & Olson, A. J. (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry, 19(14), 1639–1662. https://doi.org/10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   Web of Science ®Google Scholar
• Moussion, C., Ortega, N., & Girard, J. P. (2008). The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: A novel “Alarmin”? PLoS One, 3(10), e3331. https://doi.org/10.1371/journal.pone.0003331
   PubMed Web of Science ®Google Scholar
• O’Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 3(10), 3. https://doi.org/10.1186/1758-2946-3-3
   PubMedGoogle Scholar
• Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera – A visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/10.1002/jcc.20084
   PubMed Web of Science ®Google Scholar
• Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kalé, L., & Schulten, K. (2005). Scalable molecular dynamics with NAMD. Journal of Computational Chemistry, 26(16), 1781–1802. https://doi.org/10.1002/jcc.20289
   PubMed Web of Science ®Google Scholar
• Savenije, O. E. M., Kerkhof, M., Reijmerink, N. E., Brunekreef, B., De Jongste, J. C., Smit, H. A., Wijga, A. H., Postma, D. S., & Koppelman, G. H. (2011). Interleukin-1 receptor-like 1 polymorphisms are associated with serum IL1RL1-a, eosinophils, and asthma in childhood. Journal of Allergy and Clinical Immunology, 127(3), 750–756.E5. https://doi.org/10.1016/j.jaci.2010.12.014
   PubMed Web of Science ®Google Scholar
• Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., Mcclanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., Gorman, D. M., Bazan, J. F., & Kastelein, R. A. (2005). IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity, 23, 479–490. https://doi.org/10.1016/j.immuni.2005.09.015
   PubMed Web of Science ®Google Scholar
• Trott, O., & Olson, A. J. (2009). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31, 455–461. https://doi.org/10.1002/jcc.21334
   Web of Science ®Google Scholar